The following information was received by facsimile:
On June 4, 2013, the Radiation Safety Officer for the University of South Alabama, Mobile, Alabama, notified the Alabama Office of Radiation Control of a fetal/embryo dose that was in excess of 500 millirem.
On April 2, 2013, a 30 [year old] female was referred to the University of South Alabama Medical Center for treatment of symptomatic hyperthyroidism via Sodium Iodide-131. The patient was interviewed regarding pregnancy by the authorized user and a blood test was collected for qualitative serum hCG testing. After a negative pregnancy testing and the patient's statements, the patient was given 15 millicuries of Sodium Iodide-131. The patient was also counseled to avoid pregnancy for six months.
On May 30, 2013, eight weeks and two days later, the patient reported to her physician a positive pregnancy diagnosis by her OB/GYN physician. The patient reported that her OB/GYN physician determined that she was in the tenth week of pregnancy. This would place the patient approximately 10 days pregnant at the time of administration.
Alabama Incident: 13-27